☆ 4.7 Editorial Material

Fibrotic lung disease: A molecular glimpse into severe Covid-19?

EBIOMEDICINE (2021)

Journal

EBIOMEDICINE

Volume 69, Issue -, Pages -

Publisher

ELSEVIER

DOI: 10.1016/j.ebiom.2021.103470

Keywords

Funding

NHLBI [K23HL138190]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

A glimpse into what happens after PTCy

Mark Leick, Yi-Bin Chen

Summary: In this study, McCurdy et al compare immune restoration after haploidentical and matched donor HCT, and find that high-dose PTCy-based GVHD prophylaxis is effective in immune recovery.

BLOOD (2022)

Add to Collection

Review Medicine, General & Internal

Severe COVID-19 Lung Infection in Older People and Periodontitis

Ruben Aquino-Martinez, Scarlette Hernandez-Vigueras

Summary: Periodontal bacteria dissemination into the lower respiratory tract may increase the risk of severe COVID-19 lung infection in older patients, as bacterial infection can cause permanent damage and senescence in cells, which in turn facilitates SARS-CoV-2 replication.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Endocrinology & Metabolism

Cushing's Disease Management: Glimpse Into 2051

Rinkoo Dalan, Stefan R. Bornstein, Bernhard O. Boehm

Summary: This article discusses the significant advancements in medicine and healthcare in the 21st century Digital Age, primarily driven by the application of data technologies and artificial intelligence. A short story is shared to depict the future state for Cushing's Disease patients and the proposed diagnostic and management approaches. The article postulates a complete reinvention of endocrinology care in the Digital Age.

FRONTIERS IN ENDOCRINOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Timing of Lung Transplant Referral in Patients with Severe COVID-19 Lung Injury Supported by ECMO

Liran Levy, Ofir Deri, Ella Huszti, Eyal Nachum, Stephane Ledot, Nir Shimoni, Milton Saute, Leonid Sternik, Ran Kremer, Yigal Kassif, Nona Zeitlin, Jonathan Frogel, Ilya Lambrikov, Ilia Matskovski, Sumit Chatterji, Lior Seluk, Nadav Furie, Inbal Shafran, Ronen Mass, Amir Onn, Ehud Raanani, Amir Grinberg, Yuval Levy, Arnon Afek, Yitshak Kreiss, Alexander Kogan

Summary: Severe respiratory failure caused by COVID-19 often requires mechanical ventilation and extracorporeal membrane oxygenation (ECMO). Lung transplantation (LTx) may be considered as a last resort, but the patient selection and timing for referral and listing remain uncertain. A retrospective study analyzed severe COVID-19 patients supported by veno-venous ECMO and listed for LTx. Out of 20 patients, 16 were compared, including nine who recovered and seven who died while awaiting LTx. Younger age was significantly associated with a higher likelihood of recovery without LTx after a median of 59 days on ECMO. Referral to LTx should be delayed for 8-10 weeks after ECMO initiation, especially for younger patients with a higher probability of spontaneous recovery.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Microvascular Thrombosis as a Critical Factor in Severe COVID-19

Patricia P. Wadowski, Benjamin Panzer, Alicja Jozkowicz, Christoph W. Kopp, Thomas Gremmel, Simon Panzer, Renate Koppensteiner

Summary: Platelet-endothelial interactions play a crucial role in microcirculatory function and tissue homeostasis. COVID-19 disrupts the delicate balance between platelets and the vessel wall, leading to endothelial damage, microthrombosis, and tissue ischemia. In this opinion paper, we discuss the pathological processes that contribute to endothelial activation and thrombus formation, which may drive the deterioration of severe COVID-19 cases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Endocrinology & Metabolism

Testosterone Deficiency Is a Risk Factor for Severe COVID-19

Lukas Lanser, Francesco Robert Burkert, Lis Thommes, Alexander Egger, Gregor Hoermann, Susanne Kaser, Germar Michael Pinggera, Markus Anliker, Andrea Griesmacher, Guenter Weiss, Rosa Bellmann-Weiler

Summary: Male COVID-19 patients with lower testosterone levels upon hospital admission are associated with more advanced immune activation, severe clinical manifestations, and an increased risk for ICU admission or death.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Article Oncology

Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia: A Randomized Double-Blind Study

Alexandros Papachristofilou, Tobias Finazzi, Andrea Blum, Tatjana Zehnder, Nuria Zellweger, Jens Lustenberger, Tristan Bauer, Christian Dott, Yasar Avcu, Gotz Kohler, Frank Zimmermann, Hans Pargger, Martin Siegemund

Summary: Whole-lung low-dose radiation therapy did not improve clinical outcomes in critically ill patients requiring mechanical ventilation for COVID-19 pneumonia, with no significant differences observed in ventilator-free days or overall survival between the treatment group and sham group.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

Add to Collection

Article Medicine, General & Internal

Do worsening lung ultrasound scans identify severe COVID-19 trajectories?

Paul W. Blair, Jimin Hwang, Jackson Pearce, Tiffany C. Fong, Erjia Cui, Phabiola Herrera, Gigi Liu, Ciprian Crainiceanu, Trishul Siddharthan, Danielle V. Clark

Summary: The study found that COVID-19 patients with ICU-level or fatal peak illness had higher mean lung ultrasound scores and lower percentage of lung fields with A-lines compared to those with less severe hospitalized illness, regardless of the duration of illness. However, there were no differences in the trajectories of mean lung ultrasound scores and percentage of lung fields with A-lines between severity groups. Therefore, serial lung ultrasound scans may not be useful in monitoring the progression of COVID-19 in hospitalized adults.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Successful Lung Transplantation for Severe Post-COVID-19 Pulmonary Fibrosis

David J. Hall, Jefree J. Schulte, Erik E. Lewis, Swaroop R. Bommareddi, Charles T. Rohrer, Samir Sultan, James D. Maloney, Malcolm M. DeCamp, Daniel P. McCarthy

Summary: This article reports a case of lung transplantation for post-COVID-19 pulmonary fibrosis. The patient recovered rapidly after the surgery and has done well in follow-up.

ANNALS OF THORACIC SURGERY (2022)

Add to Collection

Article Medicine, General & Internal

Steroids Therapy in Patients With Severe COVID-19: Association With Decreasing of Pneumonia Fibrotic Tissue Volume

Jin-wei He, Ying Su, Ze-song Qiu, Jiang-jie Wu, Jun Chen, Zhe Luo, Yuyao Zhang

Summary: In this study, the effect of steroid therapy on the progression of pulmonary lesions caused by COVID-19 pneumonia was explored using longitudinal chest CT images. The results showed that steroid therapy could reduce the volume proportion of pneumonia fibrotic tissue and had a positive effect on COVID-19 recovery, which was related to the severity of the disease.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Article Pediatrics

Risk Factors for Severe COVID-19 in Children

Rebecca C. Woodruff, Angela P. Campbell, Christopher A. Taylor, Shua J. Chai, Breanna Kawasaki, James Meek, Evan J. Anderson, Andy Weigel, Maya L. Monroe, Libby Reeg, Erica Bye, Daniel M. Sosin, Alison Muse, Nancy M. Bennett, Laurie M. Billing, Melissa Sutton, H. Keipp Talbot, Keegan McCaffrey, Huong Pham, Kadam Patel, Michael Whitaker, Meredith L. McMorrow, Fiona P. Havers

Summary: This study describes population-based rates and risk factors for pediatric severe COVID-19. The study found that children under the age of 2 with chronic lung disease, neurologic disorders, cardiovascular disease, prematurity, and airway abnormality, as well as children aged 2 to 17 depending on a feeding tube, with diabetes mellitus, and with obesity, are more susceptible to severe COVID-19. The results of this study are important for identifying high-risk children and implementing prevention efforts, including vaccination.

PEDIATRICS (2022)

Add to Collection

Article Multidisciplinary Sciences

ACE2 protein expression in lung tissues of severe COVID-19 infection

Atish Gheware, Animesh Ray, Deeksha Rana, Prashant Bajpai, Aruna Nambirajan, S. Arulselvi, Purva Mathur, Anjan Trikha, Sudheer Arava, Prasenjit Das, Asit Ranjan Mridha, Geetika Singh, Manish Soneja, Neeraj Nischal, Sanjeev Lalwani, Naveet Wig, Chitra Sarkar, Deepali Jain

Summary: This study found significantly higher ACE2 protein expression in the lung tissues of deceased COVID-19 patients, which correlated with pathological changes and disease severity.

SCIENTIFIC REPORTS (2022)

Add to Collection

Review Medicine, General & Internal

Lung recovery with prolonged ECMO following fibrotic COVID-19 acute respiratory distress syndrome

Abdul W. Kazi, Ross Summer, Baskaran Sundaram, Gautam George

Summary: This article presents a case study of a COVID-19 patient with severe ARDS who required prolonged extracorporeal oxygenation and recovered lung function without lung transplantation. The patient also experienced severe pulmonary fibrosis but eventually resolved after several months of hospitalization. The article also provides a review on post-COVID-19 pulmonary fibrosis.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2023)

Add to Collection

Article Immunology

Histone H3 Cleavage in Severe COVID-19 ICU Patients

Joram Huckriede, Femke de Vries, Michael Hultstroem, Kanin Wichapong, Chris Reutelingsperger, Miklos Lipcsey, Pablo Garcia de Frutos, Robert Frithiof, Gerry A. F. Nicolaes

Summary: The severity of COVID-19 is associated with the formation of neutrophil extracellular traps (NETs) and the release of cytotoxic extracellular histones. Elevated levels of histone H3, MPO, and DNA-MPO complex in the plasma of COVID-19-positive ICU patients were observed, with histone H3 presence linked to thromboembolic events and secondary infection. Treating NET formation and targeting histones may be beneficial for severe COVID-19 patients.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Risk of severe COVID-19 in patients treated with IBD medications: a French nationwide study

Antoine Meyer, Laura Semenzato, Mahmoud Zureik, Alain Weill, Franck Carbonnel, Rosemary Dray-Spira

Summary: The study compared the risk of severe COVID-19 among patients with inflammatory bowel disease (IBD) on different medications and found that immunomodulators and biologics do not appear to increase the severity of COVID-19 infection in this population.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

Add to Collection

Review Rheumatology

Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

Paolo Spagnolo, Oliver Distler, Christopher J. Ryerson, Argyris Tzouvelekis, Joyce S. Lee, Francesco Bonella, Demosthenes Bouros, Anna-Maria Hoffmann-Vold, Bruno Crestani, Eric L. Matteson

Summary: This study discusses the different types of interstitial lung diseases (ILDs) and their association with autoimmune and connective tissue diseases (CTDs), as well as introduces drug treatment studies for some fibrosing ILDs. It emphasizes the importance of fibrosis in ILDs.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Arrhythmias in Cardiac Sarcoidosis Bench to Bedside A Case-Based Review

Lynda E. Rosenfeld, Mina K. Chung, Clifford Harding, Paolo Spagnolo, Johan Grunewald, Jason Appelbaum, William H. Sauer, Daniel A. Culver, Jose A. Joglar, Ben A. Lin, Christine L. Jellis, Timm-Michael Dickfeld, Deborah H. Kwon, Edward J. Miller, Paul C. Cremer, Frank Bogun, Jordana Kron, Ashley Bock, Davendra Mehta, Paul Leis, Konstantinos C. Siontis, Elizabeth S. Kaufman, Thomas Crawford, Peter Zimetbaum, Edwin T. Zishiri, Jagmeet P. Singh, Kenneth A. Ellenbogen, Jonathan Chrispin, Syed Quadri, Logan L. Vincent, Kristen K. Patton, Steven Kalbfleish, Thomas D. Callahan, Francis Murgatroyd, Marc A. Judson, David Birnie, David R. Okada, Christopher Maulion, Pavan Bhat, Lavanya Bellumkonda, Ron Blankstein, Richard K. Cheng, Maryjane A. Farr, Jerry D. Estep

Summary: Cardiac sarcoidosis, a component of a multiorgan granulomatous disease, is being increasingly recognized due to heightened awareness and new diagnostic tests like cardiac magnetic resonance imaging and F-18-fluorodeoxyglucose positron emission tomography scans. Early diagnosis using these tools is crucial for potentially life-saving measures, and treatment options including those related to heart failure and disease mechanisms play an important role in patient care.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Critical Review of the Evolution of Extracellular Vesicles' Knowledge: From 1946 to Today

Erica Bazzan, Mariaenrica Tine, Alvise Casara, Davide Biondini, Umberto Semenzato, Elisabetta Cocconcelli, Elisabetta Balestro, Marco Damin, Claudia Maria Radu, Graziella Turato, Simonetta Baraldo, Paolo Simioni, Paolo Spagnolo, Marina Saetta, Manuel G. Cosio

Summary: Extracellular vesicles (EVs) are a family of particles/vesicles found in blood and body fluids, playing important roles in cell communication and regulation of cell processes. Recent years have seen increased interest in the content and function of EVs, but this has also led to confusion in their classification and naming. This review analyzes the evolution of knowledge and definition of EVs over the years.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Medicine, General & Internal

Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis

Nicol Bernardinello, Simone Petrarulo, Elisabetta Balestro, Elisabetta Cocconcelli, Marcel Veltkamp, Paolo Spagnolo

Summary: Sarcoidosis is a complex multisystem disorder with variable clinical presentations, making diagnosis challenging. While many patients are asymptomatic or have a benign course, a significant proportion may develop chronic or progressive disease requiring long-term therapy. Careful exclusion of alternative diagnoses is crucial in the diagnostic approach to sarcoidosis.

DIAGNOSTICS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases

Francesco Amati, Anna Stainer, Marco Mantero, Andrea Gramegna, Edoardo Simonetta, Giulia Suigo, Antonio Voza, Anoop M. Nambiar, Umberto Cariboni, Justin Oldham, Philip L. Molyneaux, Paolo Spagnolo, Francesco Blasi, Stefano Aliberti

Summary: Interstitial lung diseases are a complex group of diseases with unclear causes and mechanisms of progression. Recent research suggests that the lung microbiome may play a role in the development and progression of these diseases. However, the specific mechanisms are not yet understood. This review aims to discuss the role of altered lung microbiome in various interstitial lung diseases. Understanding the interaction between the host and microbiome in the lungs is a priority for research on these diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Pathologic comparison of conventional video-assisted thoracic surgical (VATS) biopsy versus non-intubated/awake biopsy in fibrosing interstitial lung diseases

Giulio Rossi, Paolo Spagnolo, Wim A. Wuyts, Christopher J. Ryerson, Mirca Valli, Ilaria Valentini, Giorgio Grani, Alessandra Gennari, Tommaso Bizzarro, Luigi Lazzari-Agli

Summary: Non-intubated/awake surgical lung biopsy was compared to conventional VATS biopsy in patients with F-ILD. The two procedures showed similar identification of histopathological features, but awake biopsy had significantly higher patient age and diagnostic confidence. Both procedures had a 100% diagnostic yield and similar distribution of ILD diagnoses. Awake biopsy has the potential to become the standard surgical procedure in F-ILD patients, but larger studies are needed for validation.

RESPIRATORY MEDICINE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

RNA Sequencing of Epithelial Cell/Fibroblastic Foci Sandwich in Idiopathic Pulmonary Fibrosis: New Insights on the Signaling Pathway

Fiorella Calabrese, Francesca Lunardi, Veronica Tauro, Federica Pezzuto, Francesco Fortarezza, Luca Vedovelli, Eleonora Faccioli, Elisabetta Balestro, Marco Schiavon, Giovanni Esposito, Stefania Edith Vuljan, Chiara Giraudo, Dario Gregori, Federico Rea, Paolo Spagnolo

Summary: This study identified distinct molecular signatures in the sandwich structure of epithelial cells and fibroblastic foci in patients with idiopathic pulmonary fibrosis. It provides new insights into the pathogenetic pathways of the disease and suggests potential therapeutic targets.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Respiratory System

Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe

Theodoros Karampitsakos, Paolo Spagnolo, Nesrin Mogulkoc, Wim A. Wuyts, Sara Tomassetti, Elisabeth Bendstrup, Maria Molina-Molina, Effrosyni D. Manali, Omer Selim Unat, Francesco Bonella, Nicolas Kahn, Lykourgos Kolilekas, Elisabetta Rosi, Leonardo Gori, Claudia Ravaglia, Venerino Poletti, Zoe Daniil, Thomas Skovhus Prior, Ilias C. Papanikolaou, Samantha Aso, Stavros Tryfon, Despoina Papakosta, Vasillios Tzilas, Elisabetta Balestro, Spyridon Papiris, Katerina Antoniou, Demosthenes Bouros, Athol Wells, Michael Kreuter, Argyris Tzouvelekis

Summary: This study aimed to create a large database for patients with idiopathic pulmonary fibrosis (IPF) and lung cancer in Europe. The results showed that 10.2% of IPF patients also had lung cancer, and IPF patients with lung cancer had a higher risk of all-cause mortality. Lung cancer patients who received antifibrotic treatment had lower all-cause mortality, and surgically treated IPF patients with operable lung cancer had lower all-cause mortality.

RESPIROLOGY (2023)

Add to Collection

Article Medicine, General & Internal

Chronic Bronchitis Affects Outcomes in Smokers without Chronic Obstructive Pulmonary Disease (COPD)

Alvise Casara, Graziella Turato, Marta Marin-Oto, Umberto Semenzato, Davide Biondini, Mariaenrica Tine, Nicol Bernardinello, Elisabetta Cocconcelli, Pablo Cubero, Elisabetta Balestro, Paolo Spagnolo, Jose M. Marin, Manuel G. Cosio, Marina Saetta, Erica Bazzan

Summary: Chronic bronchitis (CB) significantly affects symptoms, quality of life, and survival in smokers without COPD, with 27% of noCOPD smokers having CB. CB does not impact FEV1 decline in noCOPD but does significantly in COPD patients.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Sarcoidosis and COVID-19: At the Cross-Road between Immunopathology and Clinical Manifestation

Claudio Tana, Francesco Cinetto, Cesare Mantini, Nicol Bernardinello, Marco Tana, Fabrizio Ricci, Andrea Ticinesi, Tiziana Meschi, Riccardo Scarpa, Francesco Cipollone, Maria Adele Giamberardino, Paolo Spagnolo

Summary: COVID-19 and sarcoidosis are two diseases with similar clinical manifestations, and they may interact with each other in terms of immune system dysregulation, inflammatory response, and disease course. Sarcoidosis patients are at a higher risk of developing severe COVID-19 pneumonia due to underlying lung disease and immunosuppressive treatment. This review discusses the interactions between these two diseases in terms of clinical manifestations, treatment, and pathogenesis.

BIOMEDICINES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Radiological Assessment in Idiopathic Pulmonary Fibrosis (IPF) Patients According to MUC5B Polymorphism

Elisabetta Cocconcelli, Nicol Bernardinello, Chiara Giraudo, Gioele Castelli, Clorinda Greco, Roberta Polverosi, Marina Saetta, Paolo Spagnolo, Elisabetta Balestro

Summary: The MUC5B rs35705950 genotype has a significant impact on the radiological patterns and prognosis of IPF patients. GG carriers are more prone to increased ground glass and honeycombing extent, and have worse survival compared to T allele carriers.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Molecular Mechanism in the Development of Pulmonary Fibrosis in Patients with Sarcoidosis

Elisabetta Cocconcelli, Nicol Bernardinello, Gioele Castelli, Simone Petrarulo, Serena Bellani, Marina Saetta, Paolo Spagnolo, Elisabetta Balestro

Summary: Sarcoidosis is a disease where granulomas form in various organs, particularly the lungs. The course of the disease can be unpredictable, with some patients experiencing spontaneous remission while others develop chronic lung disease. The mechanism leading to fibrosis in advanced pulmonary sarcoidosis is still unknown, but recent studies have shed light on the genetic and immune factors involved. This review aims to summarize the clinical-prognostic characteristics and molecular pathways associated with the development of advanced pulmonary sarcoidosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Medicine, General & Internal

Occupational interstitial lung diseases

Paolo Spagnolo, Christopher J. J. Ryerson, Sabina Guler, Johanna Feary, Andrew Churg, Andrew P. P. Fontenot, Sara Piciucchi, Zarir Udwadia, Tamera J. J. Corte, Wim A. A. Wuyts, Kerri A. A. Johannson, Vincent Cottin

Summary: Millions of workers, especially in developing countries, are exposed to substances that can cause occupational interstitial lung diseases (ILDs), but the burden of the disease could be underestimated due to under-recognition and under-reporting. The diagnosis of occupational ILD requires suspicion and a thorough occupational history, as it can be difficult to distinguish between occupational and non-occupational ILDs. Considering the potential occupational cause of ILD is important, as removing workplace exposure can lead to significant improvement.

JOURNAL OF INTERNAL MEDICINE (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Environmental Causes of Idiopathic Pulmonary Fibrosis

Sheiphali Gandhi, Roberto Tonelli, Margaret Murray, Anna Valeria Samarelli, Paolo Spagnolo

Summary: Idiopathic pulmonary fibrosis (IPF) is a common and severe disease that primarily affects middle-aged and elderly males. In addition to aging, occupational and environmental exposures, as well as lifestyle factors such as smoking and diet, have been associated with an increased risk of IPF. Trigger factors may also lead to acute exacerbations and poor prognosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

No Data Available

Fibrotic lung disease: A molecular glimpse into severe Covid-19?

Journal

Publisher

ELSEVIER

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper